Big Pharma Sues to Stop Trump’s GLOBE Rule Tying Medicare Drug Payments to Foreign Prices
PhRMA filed suit a week after CMS finalized GLOBE, a most-favored-nation model that benchmarks some Medicare Part B drug rebates to prices in 19 wealthy countries.